Comprehensive management of advanced urothelial carcinoma with multiple metastatic sites.
This specialized protocol addresses advanced stage 4 urethral urothelial carcinoma with metastases to lung, lymph nodes, and brain. Our comprehensive approach utilizes multi-modality nuclear medicine imaging to assess widespread metastatic disease, monitor systemic therapy effectiveness, and guide palliative interventions. The protocol integrates PET-CT with brain imaging and provides detailed assessment of treatment response across multiple organ systems, supporting optimal management of complex metastatic disease.
Patients with advanced urethral urothelial carcinoma, multiple metastatic sites, or complex disease requiring comprehensive monitoring.
Complete the form below to begin your treatment journey with our comprehensive cancer care protocol